Xiao Jian

5PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 10, 2024
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.

De-Shen Wang, Chao Ren, Shan-Shan Li

|Nov 08, 2022
Docetaxel and fluorouracil as first-line therapy for gastric cancer with bone marrow metastasis and disseminated intravascular coagulation.

Zhai Xiaohui, Li Shanshan, Cao Taiyuan

|Aug 05, 2022
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study).

Feng Wang, Ming-Ming He, Jian Xiao

|Aug 09, 2021
Nomogram for Predicting Survival in Advanced Gastric Cancer after Neoadjuvant Chemotherapy and Radical Surgery.

Yonghe Chen, Dan Liu, Jian Xiao

Pageof 1

Frequent Collaborators

2 joint publications

Yu-Hong Li

2 joint publications

Rui-Hua Xu

2 joint publications

Hui-Yan Luo

2 joint publications

Zhi-Qiang Wang